Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...
Following laparoscopic cholecystectomy, the incidence of postoperative urinary retention is lower with sugammadex than with neostigmine used for reversal of neuromuscular blockade, a study shows.
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." While lorazepam has been the talk of the town thanks to The White Lotus, there’s another med competing ...
Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...
Individuals who are simultaneously taking certain antidepressants and beta blockers had a decrease in systolic blood pressure (BP) and an increase in their risk for bradycardia, according to new data ...
Two systematic reviews revealed very low-certainty evidence on outcomes for people with gender dysphoria. (HealthDay News) — There is considerable uncertainty regarding the effects of puberty blockers ...
A leading endocrinologist with the Food and Drug Administration recommended pursuing approval for puberty blockers for youth with gender dysphoria despite acknowledging that they raised the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results